‘One of the most positive announcements since Brexit’: UK lawyers react to new Horizon funding deal

Today, the British scientific community woke to the news that the UK has finally rejoined Horizon Europe, the European Union’s €95.5 billion ($102 billion) research funding programme.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Horizon crosses the Atlantic to acquire Raptor for $800m

14 September 2016 Irish drugs producer Horizon Pharma has entered into a definitive agreement with Raptor Pharmaceuticals in which Horizon will buy the US biopharmaceutical company for $800 million.

Americas

Horizon agrees licensing deal over anti-inflammatory drug

18 September 2015 Drugs company Horizon Pharma has agreed to settle a patent dispute centring on a proposed generic version of its anti-inflammatory drug Pennsaid.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Trump’s march-in rights threat: Why pharma is rethinking collaborations

GSK escalates mRNA COVID-19 vaccine dispute

The flaw that landed Sanofi a win in the rare disease space

Sandoz blocked by UK court from seeking Xarelto profits

An update on patenting in Ukraine, Russia and Eurasia

‘One of the most positive announcements since Brexit’: UK lawyers react to new Horizon funding deal

More on this story

Editor's picks

Editor's picks

More features